14.24 +0.08 (0.56%)
VTIV
Stock Details
Last Trade:14.24 Change:+0.08 (0.56%) Prev Close:14.16 Open: 14.20 Days Range:14.07 – 14.32 52 Week Range: 6.60 - 18.97 Volume:133671 P/E: N/AEPS:-3.99
View AllRecent Alerts 02/09/10
Recent Alert on 01/05/10 at 9:30am
inVentiv Health (VTIV) Acquires Pharmaceutical Consulting Company ParagonRx
inVentiv Health (VTIV) Acquires Pharmaceutical Consulting Company ParagonRx
inVentiv Health, Inc. (NASDAQ: VTIV) today announced it has acquired ParagonRx, a leading consulting company specializing in pharmaceutical risk management and optimizing medication use. The addition of ParagonRx will position inVentiv as the... Read More
Recent Alert on 12/02/09 at 8:56am
Opexa Thera (OPXA) Hires Jay Thompson to Further Develop Tovaxin; Dawn McGuire to Become Chief Medical Officer
Opexa Thera (OPXA) Hires Jay Thompson to Further Develop Tovaxin; Dawn McGuire to Become Chief Medical Officer
Recent Alert on 12/02/09 at 8:56am
Opexa Thera (OPXA) Hires Jay Thompson to Further Develop Tovaxin; Dawn McGuire to Become Chief Medical Officer
Opexa Thera (OPXA) Hires Jay Thompson to Further Develop Tovaxin; Dawn McGuire to Become Chief Medical Officer
Recent Alert on 11/12/09 at 2:53pm
Repros Therapeutics (RPRX) Appoints Jaye Thompson to Board; Other Management Changes
Repros Therapeutics (RPRX) Appoints Jaye Thompson to Board; Other Management Changes
View AllRecent Press Releases
Press Release on 02/09/10 at 9:05am
FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products
FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products
Press Release on 02/05/10 at 9:00am
inVentiv Health to Announce Fourth Quarter and 2009 Full-Year Results and Conduct Conference Call on February 24
inVentiv Health to Announce Fourth Quarter and 2009 Full-Year Results and Conduct Conference Call on February 24
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 12/23/08 at 12:15pm
Analyst upgrades, downgrades and initiations: AXYS, CX, EPG, CKP, CBS ...
Analyst upgrades, downgrades and initiations: AXYS, CX, EPG, CKP, CBS ...
Blog Posts on 12/23/08 at 11:45am
Analyst upgrades, downgrades and initiations: AXYS, CX, EPG, CKP, CBS
Analyst upgrades, downgrades and initiations: AXYS, CX, EPG, CKP, CBS
Blog Posts on 12/23/08 at 7:38am
Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)
Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)